TopicPharmaceutical companies

Topic: Pharmaceutical companies

Govt repeats warning to pharma firms, says don’t ‘promote products in unethical ways’

Himani Chandna - 3 November, 2020

In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.

US FDA warns pharma giant Mylan over poor quality control at its Telangana plant

Anna Edney - 2 September, 2020

US FDA inspected Mylan’s plant in Pashamylaram, Telangana, and found it hadn’t taken proper precautions to ensure solvents didn’t contain impurities.

Modi govt to form standing committee to prevent drugmakers from evading price control

Himani Chandna - 16 August, 2020

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Glenmark’s favipiravir under govt scanner for ‘false claims’, cost, DCGI seeks clarification

Himani Chandna - 19 July, 2020

Complaint by MP to DCGI also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.

2 die at pharma plant after Vizag sees another gas leak in less than 2 months

PTI - 30 June, 2020

Four people were hospitalised after benzene gas leaked at the Sainor Life Sciences company. The cause of the leak is yet to be determined.

Indian drugmaker Lupin voluntarily recalls metformin variant, a diabetes drug, in US

Himani Chandna - 12 June, 2020

India has said it is monitoring the US FDA updates, which said an extended-release variant of the drug had higher levels of a cancer-causing substance.

AstraZeneca-Gilead deal might not actually happen, say analysts

William Canny - 8 June, 2020

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak.

Big pharma is looking beyond coronavirus with AstraZeneca eyeing merger with Gilead

John Lauerman - 8 June, 2020

The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.

Don’t distract doctors with online promotion of brands amid Covid: Modi govt to pharma firms

Himani Chandna - 28 May, 2020

Order does not clarify what kind of promotions should not be done. Pharma lobbies said they would reach out to govt for clarification.

26 pharma firm employees test positive for Covid-19 in Ahmedabad

PTI - 7 May, 2020

95 other employees have been put under home-quarantine, and the company's manufacturing unit and all of Dholka town have been sanitised.

123 Page 2 of 3

On Camera

YourTurn

Guidelines for YourTurn submissions

ThePrint Team - 28 May, 2021

Opinion

Quran says no one can limit others’ freedom. Udaipur killing violates Islam’s golden rule

Raamish Siddiqui - 30 June, 2022

Throughout history, Islamic scholars have uniformly agreed that respecting and obeying the law of the land is an essential aspect of faith.

You won’t get rid of me Pakistan – I am your General, Top Gun, donkey farmer

30 June, 2022

Scorpio-N ticks all boxes in the city. Want an old-school offroader? Go for the Thar

30 June, 2022

Economy

RBI intervenes with multi-pronged strategy in battle against rupee fall

Subhadip Sircar - 30 June, 2022

The Reserve Bank’s challenges include crashes in forward dollar premiums to rising open interest in futures that adds to pressure on the currency.

Topic: Pharmaceutical companies

On Camera

YourTurn

Guidelines for YourTurn submissions

Opinion

Quran says no one can limit others’ freedom. Udaipur killing violates Islam’s golden rule

You won’t get rid of me Pakistan – I am your General, Top Gun, donkey farmer

Scorpio-N ticks all boxes in the city. Want an old-school offroader? Go for the Thar

Economy

RBI intervenes with multi-pronged strategy in battle against rupee fall

Defence

Almost 4,000 enrol for IAF’s Agnipath recruitment scheme on day 1 of online registrations

National Interest

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Follow us